Percutaneous Transluminal Septal Myocardial Ablation and Common Procedural Complications Before and After the Approval of Ablysinol

This poster examines the frequency of percutaneous transluminal septal myocardial ablation (PTSMA) and common procedural complications before and after approval of Ablysinol using the FDA Sentinel System. It was presented at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.